Sir, Bilateral congenital hamartomas of the retinal pigment epithelium in a patient with Down's syndrome Congenital hamartoma of the retinal pigment epithelium (RPE) was first described by Laqua 1 in 1981, based on the clinical observation in two cases. Since then, not more than 20 unilateral cases of RPE hamartomas have been reported in the literature. We report a rare case of bilateral RPE hamartomas found in a patient with Down's syndrome.
Case report
A 48-year-old man with Down's syndrome came recently to the United Kingdom from abroad and was seen for the first time by an optician. He was found to have bilateral macular pigmented lesions in addition to significant refractive errors. Best-corrected visual acuity was difficult being around 6/24. Fundus examination revealed bilateral, jet black, and full-thickness retinal lesions located at the fovea (Figure 1 ). The diagnosis of bilateral RPE hamartomas was reported.
Comment RPE hamartomas are focal, nodular, and jet-black lesions that usually appear to involve the full thickness of the retina and spill onto the inner retinal surface in an umbrella fashion.
2 They occur at the macular area and are not associated with any changes in the surrounding tissues. Three patterns of involvement are described: superficial involvement of the retina, full-thickness retinal involvement with preretinal extension, or fullthickness retinal involvement with preretinal extension Visual acuity is usually normal, but visual loss can occur from surrounding foveal traction or central foveal involvement. They generally remain stable without growth. The differential diagnosis includes congenital hypertrophy of the RPE, combined with hamartoma of the retina and RPE, adenoma or adenocarcinoma of the RPE, and RPE hyperplasia. Even though they are extremely infrequent, congenital RPE hamartomas have a very distinct appearance and can be recognised solely on their clinical features, most commonly being unilateral. (Figure 1 ). All topical treatment to the right eye was stopped; the choroidal detachment resolved over 5 months but the IOP rose to 25 mmHg, so travoprost was commenced. After 3 weeks , he again presented with right 360-degree choroidal detachment and IOP of 4 mmHg. Travoprost treatment was stopped, the choroidal detachment resorbed, but the IOP increased to 26 mmHg. A dorzolamide-timolol fixed combination was prescribed, maintaining IOP at 15 mmHg, with no sign of recurrent choroidal detachment to date.
Recommencement of topical ocular hypotensives following surgery is also known to precipitate hypotony and ciliochoroidal detachment. Discontinuation of topical therapy results in reattachment. 1 Prostaglandin analogues increase uveoscleral outflow of aqueous, possibly by relaxation of the ciliary muscle associated with increased metalloproteinase activity. Choroidal detachment after the use of topical latanoprost has been reported previously. 2, 3 To our knowledge, choroidal detachment has not been previously reported with topical travoprost after glaucoma filtration surgery, although there are reports of choroidal detachment in eyes with chronic angle closure, but no history of glaucoma surgery. 4 As the uveoscleral pathway is pressure-independent, it has been suggested that prostaglandin analogues could lower IOP below episcleral venous pressure, and thereby cause hypotony and choroidal detachment. 5 We, therefore, suggest that in patients who have undergone previous glaucoma surgery who subsequently need topical antihypotensive medication, prostaglandin analogues should be used with caution, as they may precipitate hypotony and choroidal detachment. 
